5nm Endotoxin Free Gold Nanoparticles

In workflows involving nanoparticle conjugation, toxicity studies, immunological studies, and aseptic assay workflows, the 5 nm endotoxin-free gold nanoparticles format is positioned as a defined nanoparticle configuration rather than a generic listing.

Gold nanoparticles are widely used as plasmonic labels and conjugation scaffolds because their optical response, surface chemistry and particle size can be matched to assay, imaging or sensor formats. The listed absorption maximum of 515-520 nm can help compare this size with related gold nanoparticle options.

The endotoxin-free format is selected for toxicity studies, immunological studies and aseptic assay workflows where the listed product data supports attention to endotoxin burden. It remains a nanoparticle reagent for scientific experiments, not a broad-purpose substitute for other surface chemistries.

The supplied description emphasizes controlled size distribution and defined particle morphology. Those details matter when comparing related nanoparticle products for optical response, conjugation behavior or assay consistency.

The application profile includes nanoparticle conjugation, toxicity studies, immunological studies, and aseptic assay workflows. These terms reflect the supported scientific workflows for this listing and help scientists compare related products by use case, not by material alone.

The small particle size is useful when compact labels, high particle number or minimal steric footprint are important selection factors.

For gold nanoparticle workflows, compare standard, stabilized, reactant-free, endotoxin-free and functionalized versions according to the application. The same size can behave differently depending on the surface chemistry and formulation.

For procurement and product selection, compare it with related nanoparticles by particle size, surface chemistry, formulation and listed application rather than treating all nanoparticles as interchangeable.

Application areas

• Nanoparticle conjugation with supported proteins, ligands or biomolecules
• Toxicity, nanotoxicology or exposure-response studies where listed
• Immunological studies using the specified nanoparticle formulation
• Aseptic assay workflows requiring the listed product format